Annual Total Liabilities
$247.84 M
+$2.30 M+0.94%
September 30, 2024
Summary
- As of February 28, 2025, ENTA annual total liabilities is $247.84 million, with the most recent change of +$2.30 million (+0.94%) on September 30, 2024.
- During the last 3 years, ENTA annual total liabilities has risen by +$208.48 million (+529.64%).
- ENTA annual total liabilities is now at all-time high.
Performance
ENTA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$236.83 M
-$11.01 M-4.44%
December 31, 2024
Summary
- As of February 28, 2025, ENTA quarterly total liabilities is $236.83 million, with the most recent change of -$11.01 million (-4.44%) on December 31, 2024.
- Over the past year, ENTA quarterly total liabilities has increased by +$211.00 thousand (+0.09%).
- ENTA quarterly total liabilities is now -7.98% below its all-time high of $257.35 million, reached on June 30, 2023.
Performance
ENTA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ENTA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.9% | +0.1% |
| 3 y3 years | +529.6% | +401.9% |
| 5 y5 years | +806.6% | +501.7% |
ENTA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +529.6% | -8.0% | +407.1% |
| 5 y | 5-year | at high | +806.6% | -8.0% | +760.9% |
| alltime | all time | at high | +5883.5% | -8.0% | +5617.7% |
Enanta Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $236.83 M(-4.4%) |
| Sep 2024 | $247.84 M(+0.9%) | $247.84 M(-0.8%) |
| Jun 2024 | - | $249.91 M(+1.0%) |
| Mar 2024 | - | $247.44 M(+4.6%) |
| Dec 2023 | - | $236.62 M(-3.6%) |
| Sep 2023 | $245.54 M(+354.1%) | $245.54 M(-4.6%) |
| Jun 2023 | - | $257.35 M(+350.9%) |
| Mar 2023 | - | $57.07 M(+22.2%) |
| Dec 2022 | - | $46.70 M(-13.6%) |
| Sep 2022 | $54.08 M(+37.4%) | $54.08 M(+14.6%) |
| Jun 2022 | - | $47.19 M(-2.2%) |
| Mar 2022 | - | $48.23 M(-14.2%) |
| Dec 2021 | - | $56.21 M(+42.8%) |
| Sep 2021 | $39.36 M(+28.8%) | $39.36 M(+20.8%) |
| Jun 2021 | - | $32.59 M(+2.7%) |
| Mar 2021 | - | $31.73 M(+9.4%) |
| Dec 2020 | - | $29.02 M(-5.0%) |
| Sep 2020 | $30.55 M(+11.8%) | $30.55 M(-1.9%) |
| Jun 2020 | - | $31.15 M(+13.2%) |
| Mar 2020 | - | $27.51 M(-4.1%) |
| Dec 2019 | - | $28.69 M(+4.9%) |
| Sep 2019 | $27.34 M(+33.0%) | $27.34 M(+7.7%) |
| Jun 2019 | - | $25.39 M(+0.1%) |
| Mar 2019 | - | $25.37 M(-7.4%) |
| Dec 2018 | - | $27.38 M(+33.3%) |
| Sep 2018 | $20.55 M | $20.55 M(+13.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $18.18 M(-14.4%) |
| Mar 2018 | - | $21.25 M(-8.2%) |
| Dec 2017 | - | $23.14 M(-7.3%) |
| Sep 2017 | $24.96 M(+120.1%) | $24.96 M(+66.7%) |
| Jun 2017 | - | $14.97 M(+15.6%) |
| Mar 2017 | - | $12.95 M(+26.8%) |
| Dec 2016 | - | $10.21 M(-10.0%) |
| Sep 2016 | $11.34 M(+15.1%) | $11.34 M(-12.3%) |
| Jun 2016 | - | $12.93 M(-14.8%) |
| Mar 2016 | - | $15.18 M(+7.7%) |
| Dec 2015 | - | $14.10 M(+43.1%) |
| Sep 2015 | $9.86 M(+45.8%) | $9.86 M(+3.8%) |
| Jun 2015 | - | $9.49 M(-56.2%) |
| Mar 2015 | - | $21.67 M(-0.2%) |
| Dec 2014 | - | $21.71 M(+221.2%) |
| Sep 2014 | $6.76 M(+3.9%) | $6.76 M(+3.0%) |
| Jun 2014 | - | $6.56 M(-1.1%) |
| Mar 2014 | - | $6.63 M(+44.8%) |
| Dec 2013 | - | $4.58 M(-29.6%) |
| Sep 2013 | $6.50 M(-21.0%) | $6.50 M(+23.7%) |
| Jun 2013 | - | $5.26 M(-27.5%) |
| Mar 2013 | - | $7.25 M(+15.8%) |
| Dec 2012 | - | $6.26 M(-23.9%) |
| Sep 2012 | $8.23 M(+98.8%) | $8.23 M(-95.0%) |
| Jun 2012 | - | $164.58 M(+3873.4%) |
| Sep 2011 | $4.14 M | $4.14 M |
FAQ
- What is Enanta Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals annual total liabilities year-on-year change?
- What is Enanta Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly total liabilities year-on-year change?
What is Enanta Pharmaceuticals annual total liabilities?
The current annual total liabilities of ENTA is $247.84 M
What is the all time high annual total liabilities for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual total liabilities is $247.84 M
What is Enanta Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, ENTA annual total liabilities has changed by +$2.30 M (+0.94%)
What is Enanta Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of ENTA is $236.83 M
What is the all time high quarterly total liabilities for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly total liabilities is $257.35 M
What is Enanta Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, ENTA quarterly total liabilities has changed by +$211.00 K (+0.09%)